Total Payments
$4,600
2024 Payments
$18.73
Companies
31
Transactions
263
Medicare Patients
945
Medicare Billing
$71,380
Payment Breakdown by Category
Food & Beverage$4,600 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,600 | 263 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,228 | 66 | $0 (2023) |
| GlaxoSmithKline, LLC. | $564.14 | 30 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $477.86 | 30 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $282.06 | 8 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $240.31 | 16 | $0 (2023) |
| ABBVIE INC. | $240.07 | 13 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $215.57 | 13 | $0 (2022) |
| Amgen Inc. | $187.46 | 14 | $0 (2022) |
| PFIZER INC. | $186.25 | 12 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $185.98 | 12 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18.73 | 1 | ABBVIE INC. ($18.73) |
| 2023 | $486.61 | 28 | Novo Nordisk Inc ($240.87) |
| 2022 | $1,980 | 101 | Novo Nordisk Inc ($597.34) |
| 2021 | $2,115 | 133 | Novo Nordisk Inc ($389.85) |
All Payment Transactions
263 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: DIABETES | ||||||
| 07/13/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Diabetes | ||||||
| 06/29/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $3.10 | General |
| Category: Diabetes | ||||||
| 06/14/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Diabetes | ||||||
| 05/22/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Diabetes | ||||||
| 05/03/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Diabetes | ||||||
| 05/02/2023 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 04/26/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: NEUROSCIENCE | ||||||
| 04/20/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Diabetes | ||||||
| 04/14/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Obesity | ||||||
| 04/11/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: RESPIRATORY | ||||||
| 04/04/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Diabetes | ||||||
| 03/23/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: Diabetes | ||||||
| 03/14/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: RESPIRATORY | ||||||
| 03/13/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Diabetes | ||||||
| 03/01/2023 | UPSHER-SMITH LABORATORIES LLC | ZEMBRACE SYMTOUCH (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: NEUROLOGY | ||||||
| 02/27/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Diabetes | ||||||
| 02/24/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: INSOMNIA | ||||||
| 02/22/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Cardio-renal | ||||||
| 02/19/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Diabetes | ||||||
| 02/13/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/06/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: RESPIRATORY | ||||||
| 01/30/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/19/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 92 | 98 | $20,390 | $5,275 |
| 2022 | 5 | 271 | 355 | $69,944 | $22,442 |
| 2021 | 7 | 291 | 376 | $72,296 | $23,332 |
| 2020 | 7 | 291 | 365 | $66,553 | $20,331 |
Total Patients
945
Total Services
1,194
Medicare Billing
$71,380
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 59 | $11,623 | $2,646 | 22.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 20 | 20 | $6,240 | $2,057 | 33.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 19 | $2,527 | $572.00 | 22.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 99 | 156 | $30,732 | $9,185 | 29.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 73 | 73 | $22,776 | $7,573 | 33.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 66 | 93 | $12,369 | $4,102 | 33.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 16 | 16 | $2,928 | $1,120 | 38.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 17 | 17 | $1,139 | $462.10 | 40.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 106 | 175 | $34,475 | $10,444 | 30.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 80 | 80 | $24,960 | $8,574 | 34.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 43 | 49 | $6,517 | $2,533 | 38.9% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 19 | 19 | $3,477 | $1,262 | 36.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 19 | 19 | $1,273 | $299.25 | 23.5% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 12 | 22 | $1,474 | $191.73 | 13.0% |
| 81003 | Automated urinalysis test | Office | 2021 | 12 | 12 | $120.00 | $27.00 | 22.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 99 | 157 | $30,929 | $9,112 | 29.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 60 | 60 | $18,720 | $5,664 | 30.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 55 | 68 | $9,044 | $2,673 | 29.6% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 22 | 22 | $2,046 | $1,335 | 65.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 13 | 13 | $3,939 | $1,110 | 28.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 25 | 25 | $1,675 | $392.63 | 23.4% |
| 81003 | Automated urinalysis test | Office | 2020 | 17 | 20 | $200.00 | $44.80 | 22.4% |
About Sara Hari, PAC
Sara Hari, PAC is a Medical healthcare provider based in Hermitage, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265490833.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sara Hari, PAC has received a total of $4,600 in payments from pharmaceutical and medical device companies, with $18.73 received in 2024. These payments were reported across 263 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($4,600).
As a Medicare-enrolled provider, Hari has provided services to 945 Medicare beneficiaries, totaling 1,194 services with total Medicare billing of $71,380. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical
- Location Hermitage, TN
- Active Since 05/03/2006
- Last Updated 11/30/2022
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1265490833
Products in Payments
- TRELEGY ELLIPTA (Drug) $532.35
- Ozempic (Drug) $427.02
- NURTEC ODT (Drug) $407.07
- Rybelsus (Drug) $339.44
- STIOLTO RESPIMAT (Drug) $237.88
- JARDIANCE (Drug) $225.88
- Saxenda (Drug) $218.28
- XARELTO (Drug) $198.13
- TRINTELLIX (Drug) $185.98
- Wegovy (Drug) $185.42
- FARXIGA (Drug) $185.34
- Otezla (Drug) $104.48
- MYRBETRIQ (Drug) $84.44
- ELIQUIS (Drug) $83.67
- UBRELVY (Drug) $81.35
- SOLIQUA 100/33 (Biological) $79.60
- PREMARIN (Drug) $68.84
- Aimovig (Biological) $68.71
- TOUJEO (Biological) $68.48
- VRAYLAR (Drug) $61.16
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Hermitage
Amanda Fallos, Pa-C, PA-C
Medical — Payments: $9,478
Medical $9,478
Chad Mathews, Pa-C, PA-C
Medical — Payments: $4,444
Medical $4,444
Deanna Alan
Medical — Payments: $2,941
Medical $2,941
Dustin Henegan, Pa, PA
Medical — Payments: $474.56
Medical $474.56
Ashley Myatt, Pa-C, PA-C
Medical — Payments: $199.50
Medical $199.50
Donna Price, Pa-C, PA-C
Medical — Payments: $97.71
Medical $97.71